Chris O'Brien Lifehouse
Chris O'Brien Lifehouse is a not-for-profit comprehensive cancer hospital in Sydney, Australia, treating nearly 60,000 patients annually across 12 cancer specialties, with seven regional NSW satellite clinics and an embedded research institute and digital patient engagement platform.
- Company typePrivate
- Founded2013
- HeadquartersSydney, Australia
- Headcount501–1,000
- GTM typeB2C
- OfferingServices
What Chris O'Brien Lifehouse does
Chris O'Brien Lifehouse is a not-for-profit comprehensive cancer hospital headquartered in Camperdown, Sydney, operating as The Trustee for Lifehouse Australia Trust and affiliated with NSW Health and the University of Sydney. It runs 12 cancer specialty departments (bowel/colorectal, breast, gynaecological, head and neck, lung and mesothelioma, lymphoma/leukaemia/myeloma, neurosurgery, sarcoma, skin and melanoma, upper gastrointestinal, urology/prostate, and gastroenterology) alongside medical services in radiation oncology, medical oncology, interventional oncology, pharmacy, and rapid-access clinics. The hospital treats nearly 60,000 patients per year and extends its reach through seven regional NSW satellite specialist clinics in Orange, Dubbo, Bowral, Port Macquarie, Tamworth, Nowra, and Wagga Wagga. Its technology platform includes the COBL Connect App for patient engagement, appointment management and care team communication, and Salesforce CRM for donor and supporter management. Supporting programs include COBL LivingRoom (integrative oncology and supportive care), the Arterie arts-in-healthcare program, Carterie mobile art studio, Schwartz Rounds staff wellness, a Graduate Nurse Program, and the Keith Cox Clinical Education Fund. Research output is anchored by the COBL Research Institute and clinical trials, including AI-based diagnostic imaging research for inflammatory bowel disease led by Dr Aravind Gokul Tamilarasan at the University of Sydney. Governance includes a Partnership Advisory Council of patients and carers.
The revenue model is a hybrid of public funding, private patient billing, philanthropic donations, and research/clinical-trial income. Public services are funded through NSW Health affiliation and bulk-billed via Medicare; privately insured patients access the same campus for fee-paying care. Philanthropy comes from individual donors, corporate supporters, gifts in Wills, and community fundraising events such as City2Surf and head-shave campaigns. Research revenue flows from clinical trials and grants; the Australian Government has committed $5.9 million to establish the Richard Scolyer Chair in Brain Cancer Research in partnership with the University of Sydney and Royal Prince Alfred Hospital. Customer acquisition is sales-led via referrals from GPs, specialists, and other hospitals, complemented by direct appointment booking, website, and corporate/community engagement.
Chris O'Brien Lifehouse firmographics
Firmographics- Name
- Chris O'Brien Lifehouse
- Legal name
- The Trustee for Lifehouse Australia Trust
- Website
- https://mylifehouse.org.au
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Chris O'Brien Lifehouse is a not-for-profit comprehensive cancer hospital in Sydney, Australia, treating nearly 60,000 patients annually across 12 cancer specialties, with seven regional NSW satellite clinics and an embedded research institute and digital patient engagement platform.
- Ownership category
- akta.pro rank
Chris O'Brien Lifehouse industry classification
Industry- Product category
- Specialist Cancer Hospital Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Offices of Physicians (62111)
- SIC
- Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)
- akta.pro primary industry
- Oncology & Cancer Specialty Hospitals (HLAFAHAC)
- akta.pro secondary industries
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)
Keywords
Where Chris O'Brien Lifehouse is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Australia
- HQ region
- Oceania
Offices8 records
Markets served
Chris O'Brien Lifehouse business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Public Healthcare Services: Government-funded healthcare services through NSW Health affiliation for public patients.
- Private Patient Services: Private healthcare services for privately insured patients. Located opposite RPAH, offers combination of publicly funded and private healthcare.
- Donations and Fundraising: Philanthropic donations from individuals, corporate supporters, and community fundraising events. Tax-deductible donations for cancer research and patient support.
- Clinical Trials: Research funding from clinical trials and research grants for cancer treatment development.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Chris O'Brien Lifehouse product offering
Product offeringCore offering
Chris O'Brien Lifehouse is a not-for-profit specialist cancer hospital delivering comprehensive, integrated cancer care under one roof. Core services span diagnosis, surgery, radiation oncology, medical oncology, interventional oncology, pharmacy, and supportive/integrative oncology across 12 specialty departments. The hospital complements clinical care with the COBL Research Institute for clinical trials, the COBL Connect App for patient engagement, and the COBL LivingRoom for evidence-based supportive care.
Product overview
Chris O'Brien Lifehouse is a not-for-profit comprehensive cancer centre offering integrated, patient-centred cancer care. The organisation operates as a single-platform hospital with multiple integrated service modules, combining clinical treatment (through 12 cancer specialty departments and services including Radiation Oncology, Medical Oncology, and Interventional Oncology), digital patient engagement (via the COBL Connect App), supportive care services (COBL LivingRoom integrative oncology), patient support programs (Arterie art-in-health program, Project Knitwell), and research capabilities (COBL Research Institute with clinical trials). The hospital also supports the community through the Partnership Advisory Council, Graduate Nurse Program, and Keith Cox Clinical Education Fund for staff development.
Differentiator
Problem solved
Functional benefit
Products and services
- Cancer Specialties (12 specialty departments) Comprehensive cancer treatment across twelve specialty departments delivering integrated surgical, medical and radiation oncology care for patients with cancer, including rare and complex cancers.
- Medical Services Comprehensive medical services spanning Radiation Oncology, Medical Oncology, Interventional Oncology, Pharmacy, and Rapid Access clinics for endoscopy, prostate cancer screening, and hysteroscopy.
- COBL Connect App A digital patient engagement application that enables cancer patients to access health information, communicate with care teams, and manage appointments across the hospital's services.
- COBL LivingRoom An integrative oncology and supportive care service providing evidence-based supportive care, allied health services, and complementary therapies for cancer patients alongside their medical treatment.
- COBL Research Institute and Clinical Trials A research institute conducting cancer research and clinical trials to improve outcomes for people affected by cancer, offering patients access to emerging therapies through clinical trial participation.
- Specialist Cancer Clinics Specialist outpatient clinics providing rapid-access and priority cancer screening and assessment services, including endoscopy, prostate cancer assessment, hysteroscopy, gestational trophoblastic disease, skin and melanoma, outpatient pain, head and neck, and breast cancer clinics.
- Regional Specialist Clinics (NSW satellite network) Satellite specialist clinics in regional NSW towns bringing cancer care services closer to patients living in rural and regional areas, including Orange, Dubbo, Bowral, Port Macquarie, Tamworth, Nowra, and Wagga Wagga.
Quantifiable outcome
- Achieves above NSW average survival rates for cancer treatment
- +1 more outcomes
Companies that use Chris O'Brien Lifehouse
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
Chris O'Brien Lifehouse technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability4 records
Feature2 records
Chris O'Brien Lifehouse partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- University of SydneycoreAcademic affiliation for research, education and training. Partnership in establishment of Richard Scolyer Chair in Brain Cancer Research.
- Royal Prince Alfred HospitalcoreMajor teaching hospital partnership in Sydney. Key partner in brain cancer research chair and clinical collaboration.
- Bloomfield FinancialcorePartnered to support travel and accommodation costs for rural and regional NSW cancer patients. Commits monthly donations and organizes fundraising with business partners.
- NSW HealthcoreGovernment health system affiliation providing public healthcare funding and governance framework.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Chris O'Brien Lifehouse competitors and assessment
Company assessmentBroad incumbents
- MD Anderson Cancer Center: One of the world's largest dedicated cancer hospitals located in the US. Comparable as a comprehensive, research-led cancer centre offering multidisciplinary treatment and specialist residency programs.
- Memorial Sloan Kettering Cancer Center: US-based comprehensive cancer centre combining specialist clinical care, research, and education. Comparable as a globally recognized integrated cancer hospital with academic affiliation and clinical trial capabilities.
- Princess Margaret Cancer Centre: Canada's largest dedicated cancer research and treatment hospital, part of University Health Network in Toronto. Comparable in combining specialty inpatient and outpatient oncology with embedded research.
- Royal Marsden NHS Foundation Trust: One of Europe's leading specialist cancer hospitals based in London, with a strong research-clinical integration model. Highly comparable in mission, structure, and academic-hospital affiliation.
Regional players
- Westmead Hospital Cancer Centre: Major public oncology service in western Sydney offering multidisciplinary cancer care, radiation oncology, and clinical trials. Direct competitor for NSW public oncology referrals.
- Nelune Comprehensive Cancer Centre (Prince of Wales Hospital): Major Sydney public hospital cancer centre providing chemotherapy, radiation, and surgical oncology within the South Eastern Sydney Local Health District. Competes for the same Sydney metropolitan patient pool.
- Sydney Adventist Hospital (San Cancer Centre): Major private hospital in Sydney with comprehensive cancer services including medical oncology, radiation oncology, and surgical oncology. Direct competitor for privately insured oncology patients in Sydney.
Direct peers
- Peter MacCallum Cancer Centre: Australia's largest dedicated cancer hospital, based in Melbourne. Directly comparable as a not-for-profit, research-embedded specialist cancer centre offering radiation oncology, medical oncology, surgery, and clinical trials.
- Olivia Newton-John Cancer Wellness & Research Centre: Specialist cancer hospital co-located with Austin Hospital in Melbourne. Comparable as a purpose-built, research-linked comprehensive cancer centre combining clinical treatment with wellness and supportive care programs.
Emerging players
- GenesisCare: One of Australia's largest private cancer care providers with extensive radiation oncology and medical oncology service network. Comparable as a high-volume outpatient oncology operator; partial overlap with Lifehouse's service mix.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Chris O'Brien Lifehouse social profiles
Digital presenceChris O'Brien Lifehouse compliance and trust
Trust signalCompliance1 record
Chris O'Brien Lifehouse financial estimates
Financial estimateRevenue estimate
Valuation estimate
Chris O'Brien Lifehouse leadership team
Management profileNumber of profiles
Profiles10 records
Chris O'Brien Lifehouse funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Chris O'Brien Lifehouse M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Chris O'Brien Lifehouse
What does Chris O'Brien Lifehouse do?
Chris O'Brien Lifehouse is a not-for-profit specialist cancer hospital delivering comprehensive, integrated cancer care under one roof. Core services span diagnosis, surgery, radiation oncology, medical oncology, interventional oncology, pharmacy, and supportive/integrative oncology across 12 specialty departments. The hospital complements clinical care with the COBL Research Institute for clinical trials, the COBL Connect App for patient engagement, and the COBL LivingRoom for evidence-based supportive care.
Is Chris O'Brien Lifehouse a public or private company?
Chris O'Brien Lifehouse is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Chris O'Brien Lifehouse founded?
Chris O'Brien Lifehouse was founded in 2013. It employs 501 to 1,000 people.
Where is Chris O'Brien Lifehouse based?
Chris O'Brien Lifehouse is headquartered in Sydney, Australia, in the Oceania region.
How does Chris O'Brien Lifehouse make money?
Four revenue lines are on record. Public Healthcare Services are the primary driver. The others are private Patient Services, donations and Fundraising and clinical Trials.
Who are Chris O'Brien Lifehouse's main competitors?
Broad incumbents on record are MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Princess Margaret Cancer Centre and Royal Marsden NHS Foundation Trust. Regional players are Westmead Hospital Cancer Centre, Nelune Comprehensive Cancer Centre (Prince of Wales Hospital) and Sydney Adventist Hospital (San Cancer Centre). Direct peers are Peter MacCallum Cancer Centre and Olivia Newton-John Cancer Wellness & Research Centre. GenesisCare is listed as an emerging player.
Does Chris O'Brien Lifehouse have an API?
No public API is recorded for Chris O'Brien Lifehouse.
What industry is Chris O'Brien Lifehouse in?
Chris O'Brien Lifehouse's product category is Specialist Cancer Hospital Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 622310 and its SIC code is 8060.